Faeth Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 18.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 484.51M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early ...